首页> 外文期刊>BMC Geriatrics >Atherosclerosis and Alzheimer - diseases with a common cause? Inflammation, oxysterols, vasculature
【24h】

Atherosclerosis and Alzheimer - diseases with a common cause? Inflammation, oxysterols, vasculature

机译:动脉粥样硬化和老年痴呆症-常见病因?炎症,氧固醇,脉管系统

获取原文
           

摘要

Background Aging is accompanied by increasing vulnerability to pathologies such as atherosclerosis (ATH) and Alzheimer disease (AD). Are these different pathologies, or different presentations with a similar underlying pathoetiology? Discussion Both ATH and AD involve inflammation, macrophage infiltration, and occlusion of the vasculature. Allelic variants in common genes including APOE predispose to both diseases. In both there is strong evidence of disease association with viral and bacterial pathogens including herpes simplex and Chlamydophila. Furthermore, ablation of components of the immune system (or of bone marrow-derived macrophages alone) in animal models restricts disease development in both cases, arguing that both are accentuated by inflammatory/immune pathways. We discuss that amyloid β, a distinguishing feature of AD, also plays a key role in ATH. Several drugs, at least in mouse models, are effective in preventing the development of both ATH and AD. Given similar age-dependence, genetic underpinnings, involvement of the vasculature, association with infection, Aβ involvement, the central role of macrophages, and drug overlap, we conclude that the two conditions reflect different manifestations of a common pathoetiology. Mechanism Infection and inflammation selectively induce the expression of cholesterol 25-hydroxylase (CH25H). Acutely, the production of ‘immunosterol’ 25-hydroxycholesterol (25OHC) defends against enveloped viruses. We present evidence that chronic macrophage CH25H upregulation leads to catalyzed esterification of sterols via 25OHC-driven allosteric activation of ACAT (acyl-CoA cholesterol acyltransferase/SOAT), intracellular accumulation of cholesteryl esters and lipid droplets, vascular occlusion, and overt disease. Summary We postulate that AD and ATH are both caused by chronic immunologic challenge that induces CH25H expression and protection against particular infectious agents, but at the expense of longer-term pathology.
机译:背景老化伴随着对诸如动脉粥样硬化(ATH)和阿尔茨海默氏病(AD)之类的病理的脆弱性增加。这些是不同的病理学,还是具有类似基础病理学的不同表现形式?讨论ATH和AD均涉及炎症,巨噬细胞浸润和血管系统阻塞。包括APOE在内的常见基因中的等位基因变异易患这两种疾病。在这两种方法中,都有强有力的证据表明疾病与病毒和细菌病原体(包括单纯疱疹和衣原体)相关。此外,在动物模型中消融免疫系统(或仅由骨髓衍生的巨噬细胞)的成分在这两种情况下都限制了疾病的发展,理由是两者都被炎症/免疫途径所加重。我们讨论淀粉样蛋白β,AD的一个显着特征,在ATH中也起着关键作用。至少在小鼠模型中,几种药物可有效预防ATH和AD的发展。考虑到相似的年龄依赖性,遗传基础,脉管系统的参与,感染的关联,Aβ的参与,巨噬细胞的中心作用和药物重叠,我们得出结论,这两种情况反映了共同病理学的不同表现。机制感染和炎症选择性诱导胆固醇25-羟化酶(CH25H)的表达。急性地,“免疫甾醇” 25-羟基胆固醇(25OHC)的产生可防御包膜病毒。我们目前的证据表明,慢性巨噬细胞CH25H上调通过25OHC驱动的ACAT变构活化AAC(酰基辅酶A胆固醇酰基转移酶/ SOAT),胆固醇酯和脂质滴的细胞内积累,血管闭塞和明显疾病而导致固醇的催化酯化反应。总结我们假设AD和ATH都是由慢性免疫学挑战引起的,该挑战诱导CH25H表达并针对特定的传染原进行保护,但要以长期病理为代价。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号